Performance Improvement Tool Towards the Medicines Manufacturing Pharmaceutical Companies Under Sustainable Practices

Performance Improvement Tool Towards the Medicines Manufacturing Pharmaceutical Companies Under Sustainable Practices

Kaminee Sahu (PhD Research Scholar, Pharmacy Department, Bhagwant University, Ajmer, India) and Seema Kohli (Pharmacy Dept, K.N. Polytechnic College, Jabalpur, India)
Copyright: © 2019 |Pages: 14
DOI: 10.4018/IJEEI.2019070103
OnDemand PDF Download:
No Current Special Offers


It is observed that the pollution of hospitals is escalated due to the propagation of diseases across the world. The medicine production companies are known as pharmaceutical companies; reserve the different kinds of drug stocks to be supplied to their partners. It is investigated that presently, the patient deaths are hiked due to the delay in drug delivery to hospitals by pharmaceutical companies. It became necessary for pharmaceutical companies to map own supply chain practices, so that the death cases of patients can be eliminated. Pharmaceutical companies are seeking the decision support model with computing technique, which can improve their future performance. The authors propose a model which includes sustainable practices i.e., green, agile, resilient, flexible delivery of medicines. This proposal model is value-added with a weak and strong sustainable practices identification technique. This research deals with an application of a fuzzy-based Incentre of Centroid technique on proposed sustainability and is an assessment model for identifying the ill and strong chief indices, so that pharmaceutical companies can improve performance. An empirical research case of a pharmaceutical firm is presented to exhibit the real-life application of the research work.
Article Preview

1. Introduction

The pharmaceutical supply chain has aimed to balance the drug/medicines manufacturing operations. Pharmaceutical companies are intended to produce many medicines; help to kill many panicle diseases. Pharmaceutical Companies are the considered as manufactures and delivers the medicines at right time to hospitals and save the life of many patients. The supply chain is found as complex and compound network, helps to connect the retailers from suppliers. In many cases, this network helps to reduce the cost of pharmaceutical companies is known as the pharmaceutical supply chain (PSC) (Baporikar, 2017; Juliani et al., 2017; Ocampo and & Clark, 2017; Rahmayanti & Ananda, 2017). PSC topic is received the attention from researchers due to escalation in the pollution of hospitals across the world. It is realized that presently the cases of patient’s deaths are rich due to improper and delay in drugs supply to hospitals. It forced the pharmaceutical companies to map their own PSC by using supply chain strategies. Many modern supply chain strategies are embedded with traditional PSC is called PSC strategies. A few strategies are discussed.

Green supply chain targets to eliminate the unwanted and undesirable pollutions e.g. ill-biological particles, fossil fuel, hazard particle, ill-particles, toxic gasses etc. from the each subsystem/agents of traditional SC circuit.

Supply chain flexibility is extensively measured as one of the major response to the increasing uncertainty and competition in the marketplace. With global competition rapidly intensifying and shifting to the supply chain level.

Agile supply chain deals rapid responses vs altering customer demands.

The Lean supply chain is a team-based approach to nonstop upgrading technologies/ approaches/ paths towards reducing the unworthily added activities or waste from the perspective of the clients.

Resilience supply chain quantifies the ability of firm vs external turbulence and discontinuities. This connection among these said strategies such as Green, Flexible, Agile Service, Lean, Resilient pharmaceutical supply chain is called as G-F-A-L-R pharmaceutical supply chain. To evolving the model under proposed new G-F-A-L-R pharmaceutical supply chain, the author’s conduct the further literature survey is shown in Figure 1 has shown the G-F-A-L-R pharmaceutical supply chain.

Figure 1.

G-F-A-L-R pharmaceutical supply chain


2. Literature Review

The authors conduct the literature survey in the field of drug manufacturing, pharmaceutical companies, traditional supply chain, modern PSC and fuzzy based techniques.

Complete Article List

Search this Journal:
Open Access Articles: Forthcoming
Volume 12: 2 Issues (2022): Forthcoming, Available for Pre-Order
Volume 11: 2 Issues (2021)
Volume 10: 2 Issues (2020)
Volume 9: 2 Issues (2019)
Volume 8: 2 Issues (2018)
Volume 7: 2 Issues (2017)
Volume 6: 2 Issues (2016)
Volume 5: 2 Issues (2015)
Volume 4: 4 Issues (2013)
Volume 3: 4 Issues (2012)
Volume 2: 4 Issues (2011)
Volume 1: 4 Issues (2010)
View Complete Journal Contents Listing